Axon Therapies
Pre-clinicalAxon is pioneering a frontline therapy that leverages Splanchnic Ablation for Volume Management (SAVM) to treat a root cause of heart failure.
Founded
2020
Focus
NeuroscienceMedical Devices
About
Axon is pioneering a frontline therapy that leverages Splanchnic Ablation for Volume Management (SAVM) to treat a root cause of heart failure.
Funding History
1Total raised: $8M
Seed$8MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationNashville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile